Back
Greif, Inc. 10K Form
Buy
60
GEF.B
Greif, Inc.
Last Price:
$75.33
Seasonality Move:
-0.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-08-31 | 10Q | GEF.B/Greif, Inc. Quarterly |
| 2023-06-08 | 10Q | GEF.B/Greif, Inc. Quarterly |
| 2023-03-03 | 10Q | GEF.B/Greif, Inc. Quarterly |
| 2022-09-01 | 10Q | GEF.B/Greif, Inc. Quarterly |
| 2022-06-09 | 10Q | GEF.B/Greif, Inc. Quarterly |
| 2022-03-04 | 10Q | GEF.B/Greif, Inc. Quarterly |
Receive GEF.B News And Ratings
See the #1 stock for the next 7 days that we like better than GEF.B
GEF.B Financial Statistics
Sales & Book Value
| Annual Sales: | $4.3B |
|---|---|
| Cash Flow: | $-279.6M |
| Price / Cash Flow: | 7.92 |
| Annual Sales: | $50.11 |
| Price / Book: | 1.01 |
Profitability
| EPS (TTM): | 1.07280 |
|---|---|
| Net Income (TTM): | $75M |
| Gross Margin: | $950.7M |
| Return on Equity: | 3.09% |
| Return on Assets: | 1.15% |
Greif, Inc. Earnings Forecast
Key Greif, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for GEF.B is 22.16%.
-
The Selling, General & Administrative Expenses for GEF.B have been equal to 15.30% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 164.92% of Operating Income.
-
The Net Earning history of GEF.B is 0.97% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 15 years.
Greif, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Containers & Packaging |
| Sector: | Materials |
| Current Symbol: | GEF.B |
| Website: | greif.com |
Debt
| Debt-to-Equity Ratio: | 0.49 |
|---|---|
| Current Ratio: | 1.27 |
| Quick Ratio: | 0.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.51 |
|---|---|
| Forward P/E Ratio: | 11.15 |
GEF.B Technical Analysis vs Fundamental Analysis
Buy
60
Greif, Inc. (GEF.B)
is a Buy
Is Greif, Inc. a Buy or a Sell?
-
Greif, Inc. stock is rated a BuyThe current Greif, Inc. [GEF.B] share price is $74.91. The Score for GEF.B is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.